AVENUE SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Issues related to 340b; Expiring healthcare extenders; Issues related to Priority Review Voucher (PRV) program

Medicare/Medicaid

Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.